JGC
AMGN icon

J. Goldman & Co’s Amgen AMGN Stock Holding History

J. Goldman & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$2.82M – 555
2025
Q3 		$2.82M Sell
10,000
-19,200
-66% -$5.57M 0.07% 251
2025
Q2 		$8.15M Sell
29,200
-82,100
-74% -$23.3M 0.2% 152
2025
Q1 		$34.7M Buy
+111,300
New +$32.9M 0.86% 18
2024
Q4 		– Sell
-20,000
Closed -$6.44M – 450
2024
Q3 		$6.44M Buy
+20,000
New +$6.54M 0.18% 139
2024
Q2 		– Sell
-20,000
Closed -$5.69M – 436
2024
Q1 		$5.69M Buy
20,000
+17,000
+567% +$4.97M 0.18% 140
2023
Q4 		$864K Sell
3,000
-37,000
-93% -$10.1M 0.04% 239
2023
Q3 		$10.8M Buy
+40,000
New +$9.98M 0.38% 85

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

J. Goldman & Co's AMGN Position: Q2 2026 in Review

J. Goldman & Co sold out of Amgen (AMGN) in Q2 2026, closing a stake of 9,900 shares — an estimated $3.48M sold.

J. Goldman & Co first reported a position in AMGN in Q2 2022 and held it in 10 quarters. The position peaked at $27.8M in Q3 2023. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J. Goldman & Co reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • J. Goldman & Co sold 9,900 Amgen shares in Q2 2026, an estimated $3.48M.
  • J. Goldman & Co first reported a position in Amgen in Q2 2022 and held it in 10 quarters.
  • J. Goldman & Co's Amgen position peaked at $27.8M in Q3 2023.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.